QuantaMatrix Inc. (KOSDAQ:317690)
South Korea · Delayed Price · Currency is KRW 4,160.00
+170.00 (4.26%)
At close: Apr 17, 2026
QuantaMatrix Revenue
In the year 2025, QuantaMatrix had annual revenue of 3.69B KRW with 47.70% growth. QuantaMatrix had revenue of 793.57M in the quarter ending December 31, 2025, with 74.49% growth.
Revenue
3.69B
Revenue Growth
+47.70%
P/S Ratio
22.71
Revenue / Employee
n/a
Employees
n/a
Market Cap
83.76B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.69B | 1.19B | 47.70% |
| Dec 31, 2024 | 2.50B | -620.82M | -19.91% |
| Dec 31, 2023 | 3.12B | 1.83B | 142.47% |
| Dec 31, 2022 | 1.29B | 736.16M | 133.90% |
| Dec 31, 2021 | 549.77M | -1.14B | -67.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Genoray | 108.04B |
| DRGEM | 102.75B |
| JPI Healthcare | 48.47B |
| L&K Biomed | 38.92B |
| Hironic | 32.09B |
| SELVAS Healthcare | 30.82B |
| Remed | 24.50B |
| Neofect | 16.05B |